Perrigo Announces Patent Litigation Settlement for the Generic Version of Onexton(R) Gel

DUBLIN, Oct. 26, 2017 -- (Healthcare Sales & Marketing Network) -- Perrigo Company plc (NYSE; TASE: PRGO) today announced that it has settled the Hatch-Waxman litigation relating to Onexton® Gel (clindamycin phosphate 1.2% and benzoyl peroxide 3.75%) ... Biopharmaceuticals, Generics, Dermatology, Litigation Perrigo, Valeant Pharmaceuticals, Onexton, clindamycin
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news